Lctx stock forecast

“Moving forward, we remain positive on the potential for Lineage’s cell therapy pipeline and anticipate investor appreciation for the OpRegen opportunity will increase in the coming months as additional data are presented,” the analyst added. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report If volume spikes exceed the 50-day average, short-term breakouts toward $2.40 could be in play, matching historical resistance from late